Ricardo Martins  Duarte Byrro
	
					    												
Brazil						                            
                            
						
 Research Article
												Bioequivalence Study of Two Oral Formulations of Memantine Tablets in Healthy Brazilian Volunteers after a Single Dose Administration 						
Author(s): Isabela Costa  César, Ricardo Martins  Duarte Byrro, Fabiana Fernandes de  Santana e Silva, Leonardo de  Souza Teixeira, Fernanda Crunivel  de Abreu and Gerson Antônio  PianettiIsabela Costa  César, Ricardo Martins  Duarte Byrro, Fabiana Fernandes de  Santana e Silva, Leonardo de  Souza Teixeira, Fernanda Crunivel  de Abreu and Gerson Antônio  Pianetti             
						
												
				 The bioequivalence of a single dose of memantine (Clomenac®) 10 mg tablets manufactured by Cobalt               Pharmaceuticals, Canada/Arrow Farmacêutica Ltda was compared with a reference memantine 10 mg tablets (Ebix®,               Lundbeck Inc). The single-dose, randomized-sequence, open-label, two period crossover study was conducted on               a total of 26 Brazilian healthy volunteers of both genders. Nineteen blood samples were taken during 72 h. Samples               were frozen and kept until time of analysis. Plasma concentrations of memantine were determined using a validated               UPLC-MS/MS method. Confidence intervals (CI, 90%) for the peak plasma concentration (Cmax) and area under               the concentration-time curve (AUC0-t) were determined by calculating log-transformed data. T.. View More»
				  
												DOI:
												 10.4172/jbb.1000104